Exome sequencing improves doctors’ ability to diagnose hard-to-pin-down neurogenetic disordersApril 5, 2016
A UCLA study led by Brent Fogel (Neurology) highlights the benefits of using a molecular genetic test called exome sequencing to accurately and quickly diagnose many rare neurological diseases. The process involves determining the order of all of the genes in a person’s genome. UCLA researchers concluded there are many benefits to insurance companies covering this test, given it is more efficient and less costly than the more commonly used type of genetic testing.
Read more at UCLA Newsroom